AB Biosciences
Biotechnology ResearchMassachusetts, United States2-10 Employees
AB Biosciences is a biotechnology research firm focused on engineering antibody-based biologics for diagnostic and therapeutic applications, with an emphasis on immuno-oncology. It designs protein constructs intended to modulate activities at antigenic targets and their effector molecules, supporting developments in biomedical and biopharmaceutical research. The company also offers immune-related protein reagents for use as investigational tools by researchers. Founded in 2007 and based in Concord, Massachusetts, ABB operates in the biotechnology research sector, focusing on niche biologics for diagnostic and therapeutic exploration. An example of its engineering work is the development of a recombinant replacement for traditional IVIG under the PRIM program.